Novel anti-inflammatory effects of canagliflozin involving Hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells
Vascular inflammation and disturbed metabolism are observed in heart failure and type 2 diabetes mellitus. Glycolytic enzyme hexokinase II (HKII) is upregulated by inflammation. We hypothesized that SGLT2 inhibitors Canagliflozin (Cana), Empagliflozin (Empa) or Dapagliflozin (Dapa) reduces inflammat...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2021
|
| In: |
Cardiovascular drugs and therapy
Year: 2021, Volume: 35, Issue: 6, Pages: 1083-1094 |
| ISSN: | 1573-7241 |
| DOI: | 10.1007/s10557-020-07083-w |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10557-020-07083-w Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s10557-020-07083-w |
| Author Notes: | Laween Uthman, Marius Kuschma, Gregor Römer, Marleen Boomsma, Jens Kessler, Jeroen Hermanides, Markus W. Hollmann, Benedikt Preckel, Coert J. Zuurbier, Nina C. Weber |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1903316847 | ||
| 003 | DE-627 | ||
| 005 | 20241205173813.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240923s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10557-020-07083-w |2 doi | |
| 035 | |a (DE-627)1903316847 | ||
| 035 | |a (DE-599)KXP1903316847 | ||
| 035 | |a (OCoLC)1475312940 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Uthman, Laween |e VerfasserIn |0 (DE-588)1342845765 |0 (DE-627)1903316197 |4 aut | |
| 245 | 1 | 0 | |a Novel anti-inflammatory effects of canagliflozin involving Hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells |c Laween Uthman, Marius Kuschma, Gregor Römer, Marleen Boomsma, Jens Kessler, Jeroen Hermanides, Markus W. Hollmann, Benedikt Preckel, Coert J. Zuurbier, Nina C. Weber |
| 246 | 3 | 3 | |a Novel anti-inflammatory effects of canagliflozin involving Hexokinase two in lipopolysaccharide-stimulated human coronary artery endothelial cells |
| 264 | 1 | |c 2021 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a "Published online: 13 October 2020".- S. 1083 | ||
| 500 | |a Gesehen am 23.09.2024 | ||
| 520 | |a Vascular inflammation and disturbed metabolism are observed in heart failure and type 2 diabetes mellitus. Glycolytic enzyme hexokinase II (HKII) is upregulated by inflammation. We hypothesized that SGLT2 inhibitors Canagliflozin (Cana), Empagliflozin (Empa) or Dapagliflozin (Dapa) reduces inflammation via HKII in endothelial cells, and that HKII-dependent inflammation is determined by ERK1/2, NF-κB. and/or AMPK activity in lipopolysaccharide (LPS)-stimulated human coronary artery endothelial cells (HCAECs). | ||
| 650 | 4 | |a Canagliflozin | |
| 650 | 4 | |a Endothelial cells | |
| 650 | 4 | |a Hexokinase 2 | |
| 650 | 4 | |a Inflammation | |
| 700 | 1 | |a Kuschma, Marius Christian |e VerfasserIn |0 (DE-588)1236304438 |0 (DE-627)1761644335 |4 aut | |
| 700 | 1 | |a Römer, Gregor |e VerfasserIn |4 aut | |
| 700 | 1 | |a Boomsma, Marleen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Keßler, Jens |d 1976- |e VerfasserIn |0 (DE-588)130200166 |0 (DE-627)494365412 |0 (DE-576)298058383 |4 aut | |
| 700 | 1 | |a Hermanides, Jeroen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hollmann, Markus W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Preckel, Benedikt |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zuurbier, Coert J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weber, Nina C. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular drugs and therapy |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1987 |g 35(2021), 6, Seite 1083-1094 |h Online-Ressource |w (DE-627)320429237 |w (DE-600)2003553-6 |w (DE-576)106890727 |x 1573-7241 |7 nnas |a Novel anti-inflammatory effects of canagliflozin involving Hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells |
| 773 | 1 | 8 | |g volume:35 |g year:2021 |g number:6 |g pages:1083-1094 |g extent:12 |a Novel anti-inflammatory effects of canagliflozin involving Hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10557-020-07083-w |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s10557-020-07083-w |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240923 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 130200166 |a Keßler, Jens |m 130200166:Keßler, Jens |d 910000 |d 910300 |d 50000 |e 910000PK130200166 |e 910300PK130200166 |e 50000PK130200166 |k 0/910000/ |k 1/910000/910300/ |k 0/50000/ |p 5 | ||
| 998 | |g 1236304438 |a Kuschma, Marius Christian |m 1236304438:Kuschma, Marius Christian |d 50000 |e 50000PK1236304438 |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1903316847 |e 4582676235 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"1987","publisher":"Springer Science + Business Media B.V ; Kluwer","dateIssuedDisp":"1987-","publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]"}],"id":{"issn":["1573-7241"],"zdb":["2003553-6"],"eki":["320429237"]},"pubHistory":["1.1987/88 -"],"titleAlt":[{"title":"CDT"}],"part":{"pages":"1083-1094","issue":"6","year":"2021","extent":"12","text":"35(2021), 6, Seite 1083-1094","volume":"35"},"disp":"Novel anti-inflammatory effects of canagliflozin involving Hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cellsCardiovascular drugs and therapy","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 05.12.05","Ungezählte Beil.: Suppl"],"recId":"320429237","language":["eng"],"title":[{"title_sort":"Cardiovascular drugs and therapy","title":"Cardiovascular drugs and therapy","subtitle":"CDT"}]}],"physDesc":[{"extent":"12 S."}],"id":{"eki":["1903316847"],"doi":["10.1007/s10557-020-07083-w"]},"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"name":{"displayForm":["Laween Uthman, Marius Kuschma, Gregor Römer, Marleen Boomsma, Jens Kessler, Jeroen Hermanides, Markus W. Hollmann, Benedikt Preckel, Coert J. Zuurbier, Nina C. Weber"]},"titleAlt":[{"title":"Novel anti-inflammatory effects of canagliflozin involving Hexokinase two in lipopolysaccharide-stimulated human coronary artery endothelial cells"}],"language":["eng"],"recId":"1903316847","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["\"Published online: 13 October 2020\".- S. 1083","Gesehen am 23.09.2024"],"title":[{"title":"Novel anti-inflammatory effects of canagliflozin involving Hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells","title_sort":"Novel anti-inflammatory effects of canagliflozin involving Hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells"}],"person":[{"roleDisplay":"VerfasserIn","display":"Uthman, Laween","role":"aut","family":"Uthman","given":"Laween"},{"family":"Kuschma","given":"Marius Christian","roleDisplay":"VerfasserIn","display":"Kuschma, Marius Christian","role":"aut"},{"display":"Römer, Gregor","roleDisplay":"VerfasserIn","role":"aut","family":"Römer","given":"Gregor"},{"family":"Boomsma","given":"Marleen","roleDisplay":"VerfasserIn","display":"Boomsma, Marleen","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Keßler, Jens","given":"Jens","family":"Keßler"},{"role":"aut","display":"Hermanides, Jeroen","roleDisplay":"VerfasserIn","given":"Jeroen","family":"Hermanides"},{"roleDisplay":"VerfasserIn","display":"Hollmann, Markus W.","role":"aut","family":"Hollmann","given":"Markus W."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Preckel, Benedikt","given":"Benedikt","family":"Preckel"},{"given":"Coert J.","family":"Zuurbier","role":"aut","display":"Zuurbier, Coert J.","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Weber, Nina C.","role":"aut","family":"Weber","given":"Nina C."}]} | ||
| SRT | |a UTHMANLAWENOVELANTII2021 | ||